For: | Christodoulidis G, Konstantinos-Eleftherios K, Marina-Nektaria K. Double role of depression in gastric cancer: As a causative factor and as consequence. World J Gastroenterol 2024; 30(10): 1266-1269 [PMID: 38596492 DOI: 10.3748/wjg.v30.i10.1266] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i10/1266.htm |
Number | Citing Articles |
1 |
Bryan Adrian Priego-Parra, Jose Maria Remes-Troche. Bidirectional relationship between gastrointestinal cancer and depression: The key is in the microbiota-gut-brain axis. World Journal of Gastroenterology 2024; 30(48): 5104-5110 doi: 10.3748/wjg.v30.i48.5104
|
2 |
Sima Jabbari, Kiana Sadreddini, Mohammad Molaei. Antidepressant use for mental health treatment of cancer patients; is it optimised?. Gastrointestinal Oncology: Management and Care 2025; 2(1) doi: 10.1080/29937817.2025.2474250
|
3 |
Chunhui Xi. Factors influencing quality of life in early-stage upper gastrointestinal cancer patients in Nanchong city: a qualitative study. American Journal of Translational Research 2024; 16(7): 3427 doi: 10.62347/EZON6207
|
4 |
Haochen Dai, Haiyi Yang, Rui Wang, Xuanpeng Wang, Xin Zhang. Modulating Gut Microbiota with Dietary Components: A Novel Strategy for Cancer–Depression Comorbidity Management. Nutrients 2025; 17(9): 1505 doi: 10.3390/nu17091505
|
5 |
Huan Gui, Yujie Nie, Haohua Yuan, Mengjiao Wang, Linzhao Li, Lan Zhu, Shuanghui Chen, Qianyu Jing, Quan Wan, Hang Lv, Yingjie Nie, Xiangyan Zhang. Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy. International Immunopharmacology 2025; 146: 113918 doi: 10.1016/j.intimp.2024.113918
|